You are viewing: UK Microbiology Testing Market analysis
Part of: Microbiology Testing Market (Global)

The UK Microbiology Testing Market was valued at $368 Million in 2025 and projected to reach to $447.5 Million by 2030, representing a compound annual growth rate of 3.4%. The UK microbiology testing market is positioned for steady growth through 2030, driven by ongoing NHS investment in diagnostic infrastructure and heightened awareness of antimicrobial resistance.

UK Microbiology Testing Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Microbiology Testing Market Trends and Insights

  • The UK market reflects steady expansion driven by increasing demand for diagnostic testing, infection control protocols, and antimicrobial resistance monitoring across NHS facilities and private laboratories.
  • The UK's established healthcare infrastructure and regulatory framework support consistent adoption of advanced microbiology testing technologies. Growth in the UK microbiology testing market is underpinned by rising prevalence of infectious diseases, heightened biosecurity awareness post-pandemic, and investment in laboratory automation.
  • The UK's commitment to antimicrobial stewardship and food safety standards further accelerates demand for microbiology testing services.
  • Between 2025 and 2030, the UK market will benefit from modernization of clinical laboratories and expanded testing capacity in both public and private sectors. The UK microbiology testing landscape is characterized by a mix of established diagnostic providers and emerging technology innovators.
  • Regulatory compliance with UK Health Security Agency standards and NHS procurement frameworks shapes market dynamics, while competition remains moderate due to the consolidated nature of UK laboratory services..

Key Market Statistics

  • CAGR (2025-2030) 3.4% CAGR
  • Market Size, 2025 ~USD 368 Million
  • Forecast, 2030 ~USD 447.5 Million
  • Country UK

UK Microbiology Testing Market Overview

Market Valuation :

The UK microbiology testing market is valued at £368.0 million in 2025, with projections reaching £447.5 million by 2030, demonstrating consistent growth in diagnostic capabilities across the nation.

NHS-Driven Demand :

Steady expansion is fueled by increasing diagnostic testing requirements within NHS facilities, coupled with stringent infection control protocols and mandatory antimicrobial resistance monitoring across public healthcare systems.

Growth Trajectory :

The UK market exhibits a 3.4% CAGR from 2025 to 2030, reflecting moderate but stable growth compared to the global market's 5.3% CAGR, indicating a mature yet expanding healthcare diagnostics sector.

Laboratory Infrastructure :

The UK's established network of NHS laboratories and accredited private testing facilities provides a robust foundation for microbiology testing services, supporting both routine diagnostics and specialized pathogen identification.

UK Microbiology Testing Market Dynamics

  • Regulatory compliance requirements and infection prevention initiatives across healthcare settings continue to sustain demand for comprehensive microbiology testing services.
  • The market benefits from the UK's advanced healthcare system and emphasis on evidence-based diagnostics, supporting laboratory modernization and expanded testing capabilities across both public and private sectors..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The UK microbiology testing market is valued at £368.0 million in 2025 and will reach £447.5 million by 2030 at a 3.4% CAGR.
    • The UK market is driven by antimicrobial resistance monitoring, infection control requirements, and NHS laboratory modernization initiatives.
    • Regulatory compliance with UK Health Security Agency standards and NHS procurement frameworks significantly influences UK market dynamics.
    • The UK microbiology testing sector benefits from post-pandemic biosecurity awareness and investment in laboratory automation technologies.

    Microbiology Testing Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment VIRAL (Pathogen Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.3% from 2025 to 2030
    Largest Segment TRADITIONAL MICROBIOLOGY METHODS (TMM) (Technology Type)
    Market Size Base Year (Billions) ~USD 7.4 (2025)
    Revenue Forecast (Billions) ~USD 9.58 (2030)
    Segments Covered Product, Type, Technology Type, Pathogen Type, End User, Technology, End Users

    UK Microbiology Testing Market Report Segmentation

    7 segment dimensions are covered across the global market.

    By Product

    • Consumables
    • Instruments
    • Reagents & Kits

    By Type

    • Automated Culture Systems
    • Cellular Component-Based Rapid Microbiology Testing
    • Colony Counters
    • Culture Methods
    • Growth-Based Rapid Microbiology Testing
    • Incubators
    • Manual Counting Methods
    • Mass Spectrometers
    • Microscopes
    • Microscopy Methods
    • Nucleic Acid-Based Rapid Microbiology Testing
    • Other Instruments
    • Other Traditional Microbiology Methods
    • Staining Techniques
    • Viability-Based Rapid Microbiology Testing

    By Technology Type

    • Rapid Microbiology Methods (Rmm)
    • Traditional Microbiology Methods (Tmm)

    By Pathogen Type

    • Bacterial
    • Fungal
    • Other Pathogens
    • Viral

    By End User

    • Cosmetics & Personal Care Companies
    • Environmental & Water Testing
    • Food & Beverage Companies
    • Other End Users
    • Pharmaceutical & Biotech Companies

    By Technology

    • Rapid Microbiology Methods (Rmm)
    • Traditional Microbiology Methods (Tmm)

    By End Users

    • Cosmetics & Personal Care Companies
    • Environmental & Water Testing
    • Food & Beverage Companies
    • Other End Users
    • Pharmaceutical & Biotech Companies

    Target Audience

    • NHS Trust Procurement Teams : Need market data to inform laboratory equipment purchasing decisions, service contracts, and budget allocation for microbiology testing across NHS trusts and integrated care systems.
    • Diagnostic Equipment Manufacturers : Require UK-specific market sizing, growth forecasts, and competitive intelligence to guide product development, sales strategies, and distribution partnerships within the NHS and private laboratory sectors.
    • Private Laboratory Operators : Seek market trends, demand drivers, and competitive positioning data to optimize service offerings, pricing strategies, and expansion plans within the UK's growing private diagnostics sector.
    • Healthcare Consultants & Advisors : Need comprehensive UK market analysis to support client advisory work, feasibility studies, and strategic planning for laboratory services, infection control, and diagnostic testing initiatives.
    • Investment & Venture Capital Firms : Require detailed market forecasts, growth drivers, and competitive landscape data to evaluate investment opportunities in UK microbiology testing companies and diagnostic technology startups.

    Key Companies in the UK Microbiology Testing Market

    CompanyHQOwnershipStrongest segments
    BIOMÉRIEUXFrancePublic CompanySyndromic and low-plex PCR (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE),Microbiology ID/AST and blood culture (VITEK 2, VITEK MS, VITEK REVEAL, BACT/ALERT, ETEST, API),Immunoassays and sepsis markers (VIDAS, Hybiome CLIA),
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    MERCK KGAAGermanyPublic CompanyLife Science (lab and bioprocessing),Healthcare (prescription drugs and biopharmaceuticals),Electronics (semiconductor and display materials),
    NEOGEN CORPORATIONUnited StatesPublic CompanyFood Safety diagnostics, media, and sanitation,Animal Safety reagents, instruments, and animal care products,Genomics services for livestock and companion animals,
    QIAGENNetherlandsPublic CompanySample technology consumables and instruments,Immune response (TB and transplant/viral load assays),Oncology and sexual/reproductive health assays,
    BIO-RAD LABORATORIES, INC.United StatesPublic CompanyLife Science instruments and systems,Life Science reagents and consumables,Clinical diagnostic test systems and informatics,
    BRUKERUnited StatesPublic CompanyNMR/EPR and Preclinical Imaging (BSI BioSpin),Mass Spectrometry, Molecular Diagnostics, and CALID Solutions,X-ray, AFM, and Nano-Analysis (BSI Nano),
    SHIMADZU CORPORATIONJapanPublic CompanyAnalytical and Measuring Instruments,Medical Systems,Industrial and Vacuum Machinery,
    CHARLES RIVER LABORATORIESUnited StatesPublic CompanyResearch Models and Services,Discovery and Safety Assessment,Manufacturing Solutions,
    EUROFINS SCIENTIFICLuxembourgPublic CompanyFood and Feed Testing, Assurance and Certification,Environment Testing (water, air, soil, waste, maritime),Biopharma Services and Clinical Diagnostics,
    IDEXXUnited StatesPublic CompanyCompanion Animal Group (in-clinic analyzers, SNAP tests, reference labs, telemedicine, software),Water Quality Products,Livestock, Poultry and Dairy plus Human Diagnostics,

    BIOMÉRIEUX

    bioMérieux is a French public company founded in 1963 that employs 14,894 people. The company operates in the life sciences and diagnostics sector.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. It is a major player in the life sciences and laboratory services industry.

    MERCK KGAA

    Merck KGaA is a German public company with roots dating back to 1668 and currently employs 59,077 people. The company operates across pharmaceuticals, life sciences, and specialty chemicals.

    NEOGEN CORPORATION

    Neogen Corporation is a United States-based public company founded in 1981 with 2,974 employees. The company provides food and animal safety solutions.

    QIAGEN

    QIAGEN is a Netherlands-based public company founded in 1984 with 5,500 employees. The company specializes in molecular diagnostics and life sciences technologies.

    BIO-RAD LABORATORIES, INC.

    Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. The company manufactures and distributes life science research and clinical diagnostics products.

    BRUKER

    Bruker is a United States-based public company founded in 1960 with 11,085 employees. The company develops scientific instruments and analytical solutions for research and diagnostics.

    SHIMADZU CORPORATION

    Shimadzu Corporation is a Japanese public company founded in 1875 with 14,649 employees. The company manufactures analytical and measuring instruments, medical devices, and industrial equipment.

    CHARLES RIVER LABORATORIES

    Charles River Laboratories is a United States-based public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services for drug development.

    EUROFINS SCIENTIFIC

    Eurofins Scientific is a Luxembourg-based public company founded in 1987 with 65,694 employees. The company operates a network of laboratories providing testing and analytical services across multiple industries.

    IDEXX

    IDEXX is a United States-based public company founded in 1983 with 11,000 employees. The company develops and manufactures diagnostics and software for veterinary and water testing markets.

    Reasons to Buy this Report

    • NHS Market Insights : Gain detailed understanding of public healthcare procurement patterns, NHS laboratory requirements, and infection control spending across England, Scotland, Wales, and Northern Ireland.
    • Competitive Landscape Analysis : Identify key players in UK microbiology testing, including laboratory service providers, diagnostic equipment manufacturers, and reagent suppliers operating within the NHS and private sectors.
    • Regulatory & Compliance Framework : Understand UK-specific regulatory requirements, CLIA accreditation standards, and antimicrobial resistance reporting mandates that shape market dynamics and laboratory operations.
    • Growth Opportunity Assessment : Evaluate emerging segments including rapid diagnostic testing, molecular microbiology, and point-of-care testing adoption rates specific to UK healthcare settings and patient demographics.
    • Strategic Market Positioning : Develop evidence-based strategies for market entry, partnership development, and service expansion tailored to UK healthcare economics and regional laboratory network structures.

    Frequently asked questions

    What is the current size of the UK microbiology testing market?

    The UK microbiology testing market is valued at £368.0 million in 2025 and is expected to grow to £447.5 million by 2030.

    What is the growth rate of the UK microbiology testing market?

    The UK microbiology testing market is projected to grow at a compound annual growth rate (CAGR) of 3.4% from 2025 to 2030.

    What are the main drivers of growth in the UK microbiology testing market?

    Key drivers include rising infectious disease prevalence, antimicrobial resistance monitoring requirements, NHS laboratory modernization, and post-pandemic biosecurity awareness in the UK.

    How does regulation impact the UK microbiology testing market?

    The UK microbiology testing market is shaped by UK Health Security Agency standards, NHS procurement frameworks, and antimicrobial stewardship regulations that influence testing protocols and provider selection.

    What is the competitive landscape of the UK microbiology testing market?

    The UK market features a mix of established diagnostic providers and emerging technology innovators, with moderate competition due to the consolidated nature of NHS laboratory services and private diagnostic networks.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics of the microbiology testing sector, including drivers, opportunities, restraints, challenges, and key player strategies. It aims to monitor developments across leading players, including acquisitions, product launches, expansions, agreements, and partnerships. The competitive landscape is evaluated to assess market players across various parameters within the broad categories of business and product strategy. The market size is estimated using top-down and bottom-up approaches, while market breakdown and data triangulation methods are employed to determine segment and subsegment sizes.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources included industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of the industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    Microbiology Testing Market Size, and Share

    Note 1: Others include sales managers, marketing managers, and product managers.
    Note 2: Companies are classified into tiers based on their total revenues. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both the top-down and bottom-up approaches have been used to estimate and validate the size of the small satellite market.

    The top-down and bottom-up approaches were used to estimate and validate the total size of the microbiology testing market. These methods were also widely used to estimate the sizes of various market segments. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research.
    • The revenues generated by leading players operating in the microbiology testing industry have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Microbiology Testing Market : Top-Down and Bottom-Up Approach

    Microbiology Testing Market Top Down and Bottom Up Approach

    Data Triangulation

    After determining the overall market size using the above-mentioned process, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, as applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides.

    Market Definition

    Microbiology testing involves the identification, quantification, and analysis of microorganisms, including bacteria, viruses, fungi, and protozoa, and plays a critical role in ensuring product safety, protecting public health, and preserving environmental integrity. These tests are widely used across pharmaceutical and biotech companies, food and beverage companies, environmental and water testing, cosmetics and personal-care companies, the agriculture and animal feed industry, and academic and research institutes, where they support quality control, regulatory compliance, contamination monitoring, and scientific research activities.

    Key Stakeholders

    • Manufacturers & distributors of microbiology testing solutions
    • Food & beverage companies
    • Environmental and water testing organizations
    • Pharmaceutical & biotechnology companies
    • Cosmetics & personal care companies
    • Agriculture & animal feed industry
    • Contract testing laboratories
    • Academic & research institutes
    • Government and regulatory bodies
    • Market research & consulting firms
    • Venture capitalists & investors

    Report Objectives

    • To define, segment, and forecast the global microbiology testing market by product, technology, pathogen type, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall microbiology testing market 
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to six regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the microbiology testing market using the company evaluation matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

    Available customizations:

    MarketsandMarkets offers the following customizations for this market report.

    Company Profiles

    • An additional five company profiles of players operating in microbiology testing.

    Regional Analysis

    • Further breakdown of the market segments at the country level

    Country Information

    • Additional country-level analysis of microbiology testing

     

    Get the Full Microbiology Testing Market Report

    Full forecast, segment splits, and company analysis for all Microbiology Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status